Finance

Beta
Lists
301301:SHE
Yili Chuanning Biotechnology Co Ltd
CN¥8.53
+0.24%
(+0.020) 1D
Jun 5, 10:07:34 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301301...
Open
CN¥8.68
High
CN¥8.69
Low
CN¥8.51
Mkt. cap
19.36B
Avg. vol.
9.93M
Volume
2.55M
Dividend
2.03%
Quarterly dividend
CN¥0.04
Ex-dividend date
Apr 29, 2026
P/E ratio
32.64
52-wk high
CN¥13.25
52-wk low
CN¥8.43
EPS
CN¥0.26
Shares outstanding
2.23B
No. of employees
3K
Open
CN¥8.68
High
CN¥8.69
Low
CN¥8.51
Mkt. cap
19.36B
Avg. vol.
9.93M
Volume
2.55M
Dividend
2.03%
Quarterly dividend
CN¥0.04
Ex-dividend date
Apr 29, 2026
P/E ratio
32.64
52-wk high
CN¥13.25
52-wk low
CN¥8.43
EPS
CN¥0.26
Shares outstanding
2.23B
No. of employees
3K
News stories
From sources across the web
About Yili Chuanning Biotechnology Co Ltd
CEO-
Employees3.13K
FoundedDec 10, 2010
Headquarters-
SectorBiotechnology
Websiteklcnsw.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.05B
1.09B
1.18B
1.09B
Cost of goods sold
720.23M
775.99M
981.03M
836.67M
Cost of revenue
720.23M
775.99M
981.03M
836.67M
Research and development expenses
27.54M
16.00M
18.85M
22.09M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
54.58M
56.83M
4.30M
64.17M
Operating expense
104.20M
75.86M
45.95M
103.10M
Total operating expenses
824.43M
851.85M
1.03B
939.77M
Operating income
227.20M
235.55M
153.30M
154.73M
Other non operating income
-1.83M
-10.94M
9.26M
-8.98M
EBT including unusual items
209.50M
192.27M
186.91M
138.71M
EBT excluding unusual items
219.29M
212.88M
159.94M
137.49M
Income tax expense
43.13M
35.94M
29.47M
28.69M
Effective tax rate
20.59%
18.69%
15.77%
20.68%
Other operating expenses
17.88M
1.01M
27.22M
17.15M
Net income
166.64M
156.53M
157.62M
110.73M
Net profit margin
15.85%
14.40%
13.35%
10.12%
Earnings per share
-
-
-
-
Interest and investment income
1.30M
897.08K
752.74K
674.20K
Interest expense
-10.59M
-9.41M
-3.00M
-8.93M
Net interest expenses
-9.29M
-8.52M
-2.25M
-8.25M
Depreciation and amortization charges
-
-
-
-
EBITDA
368.62M
370.98M
295.77M
297.20M
Gain or loss from assets sale
-352.14K
352.14K
-345.96K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer